Efficacy Optimizing Extension Study of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the long-term efficacy and safety of entecavir 1.0 mg/d + adefovir 10 mg/d with entecavir 0.5 mg/d + adefovir 10 mg/d for chronic hepatitis B patients with inadequate response to NUC therapy

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Nanfang Hospital of Southern Medical University
• Collaborator: Major Science and Technology Special Project of China Eleventh Five-year
• Treatments: Adefovir; Adefovir dipivoxil; Entecavir

Criteria

Inclusion Criteria:

• Subjects who completed the 104-week Dragon study.

• Subjects who are willing to participate the extension study.

Exclusion Criteria:

• Subjects who could not compliance with the protocol judged by investigators